Showing 2501-2510 of 2652 results for "".
- Brits in the Dark Over Eye Health According to Orbis UKhttps://modernod.com/news/brits-in-the-dark-over-eye-health-according-to-orbis-uk/2476651/New research reveals that over half of Brits (53%) do not get their eyes tested every 2 years as recommended, and just over 1 in 10 (11%) can’t remember the last time they went to the optician. This is despite 45% of those surveyed listing sight as their most valuable sense. The surv
- Eyenovia Enrolls First Patient in Phase 3 CHAPERONE Study for Progressive Myopiahttps://modernod.com/news/eyenovia-enrolls-first-patient-in-phase-3-chaperone-study-for-progressive-myopia/2476629/Eyenovia announced that it has initiated its MicroPine phase 3 program with the first patient enrolled in its CHAPERONE study, a US-based, multicenter, randomized, double-masked trial that will enroll more than 400 children between 3-12 years of age. CHAPERO
- Study: 3D Printed Artificial Corneas Similar to Human Oneshttps://modernod.com/news/study-3d-printed-artificial-corneas-similar-to-human-ones/2476615/When a person has a severely damaged cornea, a corneal transplant is required. However, there are 2,000 patients waiting for the cornea donation in the country as of 2018, and they wait for 6 or more years on average for the donation. For this reason, many scientists have put their efforts in dev
- Alcon Reports First Quarter 2019 Trading Updatehttps://modernod.com/news/alcon-reports-first-quarter-2019-trading-update/2476592/Alcon reported selected financial results for the first quarter ending March 31, 2019, and provided financial guidance for the current fiscal year. For the first quarter of 2019, worldwide net sales were $1.8 billion, flat on a reported basis and an increase of 4 percent on a constant currency ba
- Colorlite Colorblind Diagnostic and Correction System Now Available in the United Stateshttps://modernod.com/news/colorlite-colorblind-diagnostic-and-correction-system-now-available-in-the-united-states/2476585/The Colorlite Colorblind Diagnostic and Correction System, which has been used in Europe for more than 20 years, is now available in the United States, according to a company news release. </
- Zeiss Opens Cinema Lens Demo Center in Los Angeleshttps://modernod.com/news/zeiss-opens-cinema-lens-demo-center-in-los-angeles/2476584/For over 100 years, Zeiss has provided cinematography lenses to filmmakers at all levels. From their headquarters in Germany, each cine lens is designed and manufactured at the highest quality and exhibits the versatile look with neutral color rendition Zeiss is k
- FDA Approves Eylea for All Stages of Diabetic Retinopathyhttps://modernod.com/news/fda-approves-eylea-for-diabetic-retinopathy/2476580/Regeneron announced that the FDA has approved Eylea (aflibercept) injection to treat all stages of diabetic retinopathy (DR). The FDA approval of Eylea as a treatment for DR was based on 6-month and 1-year results from PANORAMA, a randomized, multicenter, controlled phase 3 trial that enrolled 40
- Watchful Waiting OK in Diabetic Macular Edema With Good Visionhttps://modernod.com/news/watchful-waiting-ok-in-diabetic-macular-edema-with-good-vision/2476573/Among patients with center-involved diabetic macular edema (DME) who had good visual acuity, there were no significant differences in vision loss over a 2-year period for those who were initially managed with watchful waiting as compared with those who underwent treatment with laser photocoagulat
- Optimo Medical AG Wins the ZKB Pioneer Prize in Switzerlandhttps://modernod.com/news/optimo-medical-ag-wins-the-zkb-pioneer-prize-in-switzerland/2476568/Optimo Medical’s eye surgery planning software Optimeyes was named the 2019 winner of the zkb pioneer prize, awarding the company a cheque for 98,696 Swiss Franc ($96,845 US). Optimo Medical was chosen from over 50 other startups in many industries from across Switzerland. Since 2001
- Pentosan Polysulfate Sodium Treatment Strongly Linked With Maculopathy and Vision Losshttps://modernod.com/news/pentosan-polysulfate-sodium-treatment-strongly-linked-with-maculopathy-and-vision-loss/2476563/Patients taking pentosan polysulfate sodium (PPS), which has been on the market for many years, appear to be at greater risk for a newly described maculopathy and vision loss, researchers report, according to Reuters. “Exposu